摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methyl-N-propylpyrimidin-5-amine | 360576-76-7

中文名称
——
中文别名
——
英文名称
4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methyl-N-propylpyrimidin-5-amine
英文别名
——
4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methyl-N-propylpyrimidin-5-amine化学式
CAS
360576-76-7
化学式
C18H25N3O2
mdl
——
分子量
315.415
InChiKey
GFAHRZRGKSGMME-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    56.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    正丙胺 、 5-iodo-4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methylpyrimidine 在 tris-(dibenzylideneacetone)dipalladium(0)三叔丁基膦 作用下, 以 甲苯 为溶剂, 生成 4-methoxy-2-(2-methoxy-4,6-dimethylphenyl)-6-methyl-N-propylpyrimidin-5-amine
    参考文献:
    名称:
    2-Arylpyrimidines: Novel CRF-1 receptor antagonists
    摘要:
    The design, synthesis and structure-activity relationship studies of a novel series of CRF-1 receptor antagonists, the 2-arylpyrimidines, are described. The effects of substitution on the aromatic ring and the pyrimidine core on CRF-1 receptor binding were investigated. A number of compounds with K-i values below 10 nM and lipophilicity in a minimally acceptable range for a CNS drug (cLogP < 5) were discovered. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.07.063
点击查看最新优质反应信息

文献信息

  • 5-SUBSTITUTED ARYLPYRIMIDINES
    申请人:NEUROGEN CORPORATION
    公开号:EP1233949A2
    公开(公告)日:2002-08-28
  • [EN] 5-SUBSTITUTED ARYLPYRIMIDINES<br/>[FR] ARYLPYRIMIDINES SUBSTITUEES EN POSITION 5
    申请人:NEUROGEN CORP
    公开号:WO2001068614A2
    公开(公告)日:2001-09-20
    Arylpyrimidine compounds are provided that can act as selective modulators of CRF receptors. These compounds are useful in the treatment of a number of CNS and peripheral disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.
  • 2-Arylpyrimidines: Novel CRF-1 receptor antagonists
    作者:Taeyoung Yoon、Stéphane De Lombaert、Robbin Brodbeck、Michael Gulianello、James E. Krause、Alan Hutchison、Raymond F. Horvath、Ping Ge、John Kehne、Diane Hoffman、Jayaraman Chandrasekhar、Darío Doller、Kevin J. Hodgetts
    DOI:10.1016/j.bmcl.2008.07.063
    日期:2008.8
    The design, synthesis and structure-activity relationship studies of a novel series of CRF-1 receptor antagonists, the 2-arylpyrimidines, are described. The effects of substitution on the aromatic ring and the pyrimidine core on CRF-1 receptor binding were investigated. A number of compounds with K-i values below 10 nM and lipophilicity in a minimally acceptable range for a CNS drug (cLogP < 5) were discovered. (c) 2008 Elsevier Ltd. All rights reserved.
查看更多